NEDD4: A Promising Target for Cancer Therapy

Author(s): Xiantao Ye, Lixia Wang, Bingxue Shang, Zhiwei Wang, Wenyi Wei

Journal Name: Current Cancer Drug Targets

Volume 14 , Issue 6 , 2014

Become EABM
Become Reviewer

Graphical Abstract:


The Neuronally expressed developmentally downregulated 4 (NEDD4), functioning largely as an E3 ubiquitin ligase, has been demonstrated to play a critical role in the development and progression of human cancers. In this review, to understand the regulatory mechanism(s) of NEDD4 as well as the signaling pathways controlled by NEDD4, we briefly describe the NEDD4 upstream regulators and its downstream ubiquitin substrates. Moreover, we further discuss its oncogenic roles in human malignancies. Therefore, targeting NEDD4 could be a potential therapeutic strategy for treatment of human cancers.

Keywords: Cancer, E3 ligase, NEDD4, oncogene, target, therapy, ubiquitination.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Published on: 25 August, 2014
Page: [549 - 556]
Pages: 8
DOI: 10.2174/1568009614666140725092430
Price: $65

Article Metrics

PDF: 55